Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines

Documenti analoghi

• Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines
  di: Skowron, Margaretha A., et al.
  Pubblicazione: (2015)
• Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines
  di: Skowron, Margaretha A., et al.
  Pubblicazione: (2017)
• Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines
  di: Skowron, Margaretha A., et al.
  Pubblicazione: (2019)
• Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells
  di: Höhn, Annika, et al.
  Pubblicazione: (2016)
• The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors
  di: Hoffmann, Michèle J., et al.
  Pubblicazione: (2016)